Orders In Council

PC Number: 2022-0321

Date: 2022-03-31

Whereas the Governor in Council is of the opinion, based on the declaration of a pandemic by the World Health Organization, that there is an outbreak of a communicable disease, namely coronavirus disease 2019 (COVID-19), in the majority of foreign countries;

Whereas the Governor in Council is of the opinion that the introduction or spread of COVID-19 would pose an imminent and severe risk to public health in Canada;

Whereas the Governor in Council is of the opinion that the entry of persons into Canada who have recently been in a foreign country may introduce or contribute to the spread in Canada of COVID-19 or of new variants of the virus causing COVID-19 that pose risks that differ from those posed by other variants but that are equivalent or more serious;

And whereas the Governor in Council is of the opinion that no reasonable alternatives to prevent the introduction or spread of COVID-19 are available;

Therefore, Her Excellency the Governor General in Council, on the recommendation of the Minister of Health, pursuant to section 58 of the Quarantine Act, makes the annexed Minimizing the Risk of Exposure to COVID-19 in Canada Order (Quarantine, Isolation and Other Obligations).

Attendu que la gouverneure en conseil est d’avis, compte tenu de la déclaration de pandémie de l’Organisation mondiale de la santé, que la majorité des pays étrangers est aux prises avec l’apparition d’une maladie transmissible, soit la maladie à coronavirus 2019 (COVID-19);

Attendu que la gouverneure en conseil est d’avis que l’introduction ou la propagation de la COVID-19 présenterait un danger grave et imminent pour la santé publique au Canada;

Attendu que la gouverneure en conseil est d’avis que l’entrée au Canada de personnes qui ont récemment séjourné dans un pays étranger pourrait favoriser l’introduction ou la propagation au Canada de la COVID-19 ou de nouveaux variants du virus qui cause la COVID-19, lesquels présentent des risques qui sont différents de ceux présentés par d’autres variants, mais qui sont équivalents ou plus graves;

Attendu que la gouverneure en conseil est d’avis qu’il n’existe aucune autre solution raisonnable permettant de prévenir l’introduction ou la propagation de la COVID-19 au Canada,

À ces causes, sur recommandation du ministre de la Santé et en vertu de l’article 58 de la Loi sur la mise en quarantaine, Son Excellence la Gouverneure générale en conseil prend le Décret visant la réduction du risque d’exposition à la COVID-19 au Canada (quarantaine, isolement et autres obligations), ci-après.

TABLE OF PROVISIONS

Minimizing the Risk of Exposure to COVID-19 in Canada Order (Quarantine, Isolation and Other Obligations)

PART 1

General

1.1 Definitions

1.2 Non-application

1.3 Exempted persons — conditions or requirements

PART 2

COVID-19 Tests

2.1 Entering by aircraft — Pre-boarding test

2.2 Entering by land — pre-arrival test

2.21 Entering by water — pre-arrival test

2.22 Alternative testing protocol — pre-arrival

2.3 Tests in Canada

2.4 Alternative testing protocol — on entry

2.5 Evidence of COVID-19 test — retention

PART 3

Suitable Quarantine Plan and Other Measures

3.1 Suitable quarantine plan

3.2 Suitable quarantine plan — requirement

3.3 Information — countries

3.4 Mask

PART 4

Quarantine of Asymptomatic Persons

4.1 Requirements — quarantine

4.2 Additional requirements

4.3 Unable to quarantine

4.4 Unable to quarantine — additional requirements

4.5 Exempted persons — quarantine

4.6 Exempted persons — medical reason

4.7 Exempted persons — compassionate grounds

4.8 Exempted persons — fully vaccinated persons

4.9 Exempted persons — less than 12 years of age

4.91 Contraindication

4.92 Signs and symptoms or positive test result

4.921 Signs and symptoms or positive test result — cruise ship

4.93 Exception — leaving Canada

PART 5

Isolation of Symptomatic Persons

5.1 Requirements — isolation

5.2 Additional requirements

5.3 Unable to isolate

5.4 Unable to isolate — additional requirements

5.5 Exempted persons — medical reason

5.6 Positive result — requirements

5.7 Exception — leaving Canada

PART 6

Powers and Obligations

6.1 Powers and obligations

PART 7

Amendments, Cessation of Effect, Repeal and Coming into Force

Amendments to Previous Order

7.1 Definition of previous Order

Amendments to this Order

7.3 Amendments to this Order

Cessation of Effect

7.5 May 31, 2022

Repeal

7.6

Coming into Force

7.7 March 31, 2022

SCHEDULE 1

SCHEDULE 2

Minimizing the Risk of Exposure to COVID-19 in Canada Order (Quarantine, Isolation and Other Obligations)

PART 1

General

Definitions

1.1 (1) The following definitions apply in this Order.

accredited person means a foreign national who holds a passport that contains a valid diplomatic, consular, official or special representative acceptance issued by the Chief of Protocol for the Department of Foreign Affairs, Trade and Development. (personne accréditée)

authorized representative has the same meaning as in section 2 of the Canada Shipping Act, 2001. (représentant autorisé)

Canadian Forces means the armed forces of Her Majesty raised by Canada. (Forces canadiennes)

Chief Public Health Officer means the Chief Public Health Officer appointed under subsection 6‍(1) of the Public Health Agency of Canada Act. (administrateur en chef)

COVID-19 antigen test means a COVID-19 screening or diagnostic immunoassay that

(a) detects the presence of a viral antigen indicating the presence of COVID-19;

(b) is authorized for sale or distribution in Canada or in the jurisdiction in which it was obtained;

(c) if the test is self-administered, is observed and the result is verified

(i) in person by an accredited laboratory or testing provider, or

(ii) in real time by remote audio-visual means by the accredited laboratory or testing provider who provided the test; and

(d) if the test is not self-administered, is performed by an accredited laboratory or testing provider. (Essai antigénique relatif à la COVID-19)

COVID-19 molecular test means a COVID-19 screening or diagnostic test, including a test performed using the method of polymerase chain reaction (PCR) or reverse transcription loop-mediated isothermal amplification (RT-LAMP), that is

(a) if the test is self-administered, observed and the result is verified

(i) in person by an accredited laboratory or testing provider, or

(ii) in real time by remote audio-visual means by the accredited laboratory or testing provider who provided the test; or

(b) if the test is not self-administered, performed by an accredited laboratory or testing provider. (essai moléculaire relatif à la COVID-19)

crew member means

(a) a crew member as defined in subsection 101.01‍(1) of the Canadian Aviation Regulations or a person who enters Canada only to become such a crew member;

(b) a member of a crew as defined in subsection 3‍(1) of the Immigration and Refugee Protection Regulations or a person who enters Canada only to become such a member of a crew; or

(c) a person who is re-entering Canada after having left to participate in mandatory training in relation to the operation of a conveyance and who is required by their employer to return to work as a crew member within the meaning of paragraph (a) or (b) on a conveyance within the 14-day period that begins on the day on which they return to Canada. (membre d’équipage)

cruise ship has the same meaning as in subsection 1‍(1) of Interim Order No. 2 Respecting Vessel Restrictions and Vaccination Requirements Due to the Coronavirus Disease 2019 (COVID-19) as that Order read on January 15, 2022. (navire de croisière)

dependent child has the same meaning as in section 2 of the Immigration and Refugee Protection Regulations. (enfant à charge)

evidence of a COVID-19 antigen test means written evidence of a COVID-19 antigen test that contains the following information:

(a) the name and date of birth of the person whose specimen was collected for the test;

(b) the name and civic address of the accredited laboratory or the testing provider that performed or observed the test and verified the test result;

(c) the date the specimen was collected and the test method used; and

(d) the test result. (preuve d’essai antigénique relatif à la COVID-19)

evidence of a COVID-19 molecular test means written evidence of a COVID-19 molecular test that contains the following information:

(a) the name and date of birth of the person whose specimen was collected for the test;

(b) the name and civic address of the accredited laboratory or the testing provider that performed or observed the test and verified the test result;

(c) the date the specimen was collected and the test method used; and

(d) the test result. (preuve d’essai moléculaire relatif à la COVID-19)

fully vaccinated person means a person who completed, at least 14 days before the day on which they entered Canada, a COVID-19 vaccine dosage regimen if

(a) in the case of a vaccine dosage regimen that uses a COVID-19 vaccine that is authorized for sale in Canada,

(i) the vaccine has been administered to the person in accordance with its labelling, or

(ii) the Minister of Health determines, on the recommendation of the Chief Public Health Officer, that the regimen is suitable, having regard to the scientific evidence related to the efficacy of that regimen in preventing the introduction or spread of COVID-19 or any other factor relevant to preventing the introduction or spread of COVID-19; or

(b) in all other cases,

(i) the vaccines of the regimen are authorized for sale in Canada or in another jurisdiction, and

(ii) the Minister of Health determines, on the recommendation of the Chief Public Health Officer, that the vaccines and the regimen are suitable, having regard to the scientific evidence related to the efficacy of that regimen and the vaccines in preventing the introduction or spread of COVID-19 or any other factor relevant to preventing the introduction or spread of COVID-19. (personne entièrement vaccinée)

isolation means the separation of persons who have reasonable grounds to suspect that they have COVID-19, who exhibit signs and symptoms of COVID-19 or who know that they have COVID-19, in such a manner as to prevent the spread of the disease. (isolement)

mask means any mask, including a non-medical mask, that meets all of the following requirements:

(a) it is made of multiple layers of tightly woven material such as cotton or linen;

(b) it completely covers a person’s nose, mouth and chin without gaping;

(c) it can be secured to a person’s head with ties or ear loops. (masque)

permanent resident of Canada has the meaning assigned by the definition permanent resident in subsection 2‍(1) of the Immigration and Refugee Protection Act. (résident permanent du Canada)

protected person has the same meaning as in subsection 95‍(2) of the Immigration and Refugee Protection Act. (personne protégée)

quarantine means the separation of persons in such a manner as to prevent the possible spread of disease. (quarantaine)

quarantine facility means a place that is designated under section 7 of the Quarantine Act or that is deemed to be designated under subsection 8‍(2) of that Act, and that is chosen by the Chief Public Health Officer. (installation de quarantaine)

signs and symptoms of COVID-19 include a fever and a cough or a fever and difficulty breathing. (signes et symptômes de la COVID-19)

temporary resident means a temporary resident within the meaning of the Immigration and Refugee Protection Act. (résident temporaire)

testing provider means

(a) a person who may provide COVID-19 screening or diagnostic testing services under the laws of the jurisdiction where the service is provided; or

(b) an organization, such as a telehealth service provider or pharmacy, which may provide COVID-19 screening or diagnostic testing services under the laws of the jurisdiction where the service is provided and that employs or contracts with a person referred to in paragraph (a)‍. (fournisseur de services d’essais)

vulnerable person means a person who

(a) has an underlying medical condition that makes the person susceptible to complications related to COVID-19;

(b) has a compromised immune system from a medical condition or treatment; or

(c) is 65 years of age or older. (personne vulnérable)

Interpretation — fully vaccinated person

(2) For greater certainty, for the purposes of the definition fully vaccinated person, a COVID-19 vaccine that is authorized for sale in Canada does not include a similar vaccine sold by the same manufacturer that has been authorized for sale in another jurisdiction.

Non-application

1.2 This Order does not apply to a person who

(a) enters Canadian waters, including the inland waters, or the airspace over Canada, on board a conveyance, if the person is continuously on board that conveyance while in Canada and

(i) in the case of a conveyance other than an aircraft, the person does not land in Canada and the conveyance does not make contact with another conveyance, moor or anchor while in Canadian waters, including the inland waters, other than anchoring carried out in accordance with the right of innocent passage under international law, or

(ii) in the case of an aircraft, the conveyance does not land while in Canada; or

(b) leaves Canadian waters, including the inland waters, or the airspace over Canada, on board a conveyance and then re-enters Canada on board the conveyance, if the person was continuously on board that conveyance while outside Canada and

(i) in the case of a conveyance other than an aircraft, the person did not land outside Canada and the conveyance did not make contact with another conveyance, moor or anchor while outside Canada, or

(ii) in the case of an aircraft, the conveyance did not land while outside Canada.

Exempted persons — conditions or requirements

1.3 (1) The Chief Public Health Officer may take immediate public health measures to minimize the risk of introduction or spread of COVID-19 by imposing conditions or requirements on any person or member of a class of persons exempt under this Order from any requirement set out in it, including

(a) a condition that allows for the collection of information about the likelihood of introduction or spread of COVID-19 by that person or member of a class of persons; or

(b) a requirement referred to in this Order or any similar requirement.

Compliance — conditions or requirements

(2) A person who is exempted from any requirement under this Order and on whom the conditions or requirements are imposed under subsection (1) must comply with them in order to remain exempted from the requirement.

Factors to consider

(3) For the purposes of subsection (1), the Chief Public Health Officer must consider the following factors:

(a) the risk to public health posed by COVID-19;

(b) the likelihood or degree of exposure of the person or member of the class of persons to COVID-19 prior to entry into Canada;

(c) the likelihood that the person or member of the class of persons could introduce or spread COVID-19;

(d) the extent of the spread of COVID-19 in any place where the person or member of the class of persons travelled;

(e) any scientific evidence indicating that a new variant of the virus that causes COVID-19 is spreading in a place where the person or member of the class of persons travelled;

(f) the likelihood that the person or member of the class of persons could pose an imminent and severe risk to public health in Canada; and

(g) any other factor consistent with the purposes of the Quarantine Act that the Chief Public Health Officer considers relevant.

PART 2

COVID-19 Tests

Entering by aircraft — Pre-boarding test

2.1 (1) Every person who enters Canada by aircraft must, before boarding the aircraft for the flight to Canada, provide to the aircraft operator evidence of a COVID-19 molecular test or evidence of a COVID-19 antigen test indicating that they received

(a) a negative result for a COVID-19 molecular test that was performed outside Canada on a specimen collected no more than 72 hours, or within another period set out under the Aeronautics Act, before the aircraft’s initial scheduled departure time;

(b) a negative result for a COVID-19 antigen test that was performed outside Canada on a specimen collected the day before or the day of the aircraft’s initial scheduled departure or within another period set out under the Aeronautics Act; or

(c) a positive result for a COVID-19 molecular test that was performed on a specimen collected at least 10 days and no more than 180 days before the aircraft’s initial scheduled departure time.

Exempted persons

(2) Subsection (1) does not apply to

(a) a person referred to in Table 1 of Schedule 1; and

(b) a person referred to in section 2.22.

Entering by land — pre-arrival test

2.2 (1) Every person must, when entering Canada by land,

(a) have in their possession evidence of a COVID-19 molecular test or evidence of a COVID-19 antigen test indicating that they received

(i) a negative result for a COVID-19 molecular test that was performed outside Canada on a specimen collected no more than 72 hours before they enter Canada,

(ii) a negative result for a COVID-19 antigen test that was performed outside Canada on a specimen collected the day before or the day on which they enter Canada, or

(iii) a positive result for a COVID-19 molecular test that was performed on a specimen collected at least 10 days and no more than 180 days before they enter Canada; and

(b) provide upon request the evidence referred to in paragraph (a) to the Minister of Health, screening officer or quarantine officer.

Exempted persons

(2) Subsection (1) does not apply to

(a) a person referred to in Table 2 of Schedule 1; and

(b) a person referred to in section 2.22.

Entering by water — pre-arrival test

2.21 (1) Every person must, before and when entering Canada by water,

(a) have in their possession evidence of a COVID-19 molecular test or evidence of a COVID-19 antigen test indicating that they received

(i) a negative result for a COVID-19 molecular test that was performed outside Canada on a specimen collected no more than 72 hours before they enter Canada,

(ii) a negative result for a COVID-19 antigen test that was performed outside Canada on a specimen collected the day before or the day on which they enter Canada, or

(iii) a positive result for a COVID-19 molecular test that was performed on a specimen collected at least 10 days and no more than 180 days before they enter Canada; and

(b) provide upon request the evidence referred to in paragraph (a) to the Minister of Health, screening officer or quarantine officer.

Exempted persons

(2) Subsection (1) does not apply to

(a) a person referred to in Table 3 of Schedule 1; and

(b) a person referred to in section 2.22.

Alternative testing protocol — pre-arrival

2.22 A person or any member of a class of persons who is required to provide or have in their possession evidence under paragraph 2.1‍(1)‍(a) or (b) or subparagraph 2.2‍(1)‍(a)‍(i) or (ii) or 2.21‍(1)‍(a)‍(i) or (ii) and who is designated by the Chief Public Health Officer must, before or when entering Canada, if the person enters by land or water, or before boarding the aircraft for the flight to Canada, if the person enters by air, and in accordance with the instructions of the Chief Public Health Officer,

(a) undergo a COVID-19 molecular test or a COVID-19 antigen test in accordance with an alternative testing protocol that screens or diagnoses COVID-19 for the purpose of minimizing the risk of introduction or spread of COVID-19 and that takes into account the following factors:

(i) the number of tests,

(ii) the test method of each test,

(iii) the location where each test is administered,

(iv) the frequency of the tests,

(v) the timing of the tests, and

(vi) any extraordinary circumstances;

(b) provide to the Minister of Health, screening officer or quarantine officer evidence of the COVID-19 molecular test or evidence of the COVID-19 antigen test referred to in paragraph (a)‍.

Tests in Canada

2.3 (1) Subject to subsections (1.1) and (3) to (5), every person who enters Canada must, in accordance with the instructions of a quarantine officer or the Minister of Health, undergo a COVID-19 molecular test

(a) when entering Canada; and

(b) after entering Canada.

Chief Public Health Officer — exempted persons

(1.1) Subject to subsections (3) and (4), the Chief Public Health Officer may, having regard to the factors set out in subsection 1.3‍(3), exempt from the requirements set out in paragraph (1)‍(a) or (b), or both, any person referred to in subsection (1) or any member of a class of those persons, other than the following persons:

(a) a person who is referred to in subsection 5.1‍(1);

(b) a person who is referred to in item 15 of Table 1 of Schedule 1;

(c) a fully vaccinated person who

(i) enters Canada by land from the United States at a place other than a land port of entry designated by the Minister of Public Safety and Emergency Preparedness under section 26 of the Immigration and Refugee Protection Regulations with the intent to make a claim for refugee protection, and

(ii) does not provide the evidence referred to in paragraph 2.2‍(1)‍(a); and

(d) a person who is less than 12 years of age, who is not a fully vaccinated person and enters Canada with one of their parents, step-parents, guardians or tutors who is a person referred to in paragraph (c)‍.

COVID-19 molecular test — on request

(1.2) On the request, made in a randomized manner, of the Chief Public Health Officer, a person referred to in subsection (1.1) or a member of a class of those persons must, during the 14-day period that begins on the day on which the person enters Canada, undergo a COVID-19 molecular test in accordance with the instructions of a quarantine officer or the Minister of Health.

Expense

(2) For greater certainty, the person who must undergo the COVID-19 molecular tests must do so at their expense or at the expense of another person on behalf of that person unless the COVID-19 molecular tests are provided or paid for by Her Majesty in right of Canada or an agent of Her Majesty in right of Canada or by Her Majesty in right of a province.

Extraordinary circumstances

(3) A quarantine officer may, in extraordinary circumstances, release any person from the requirement to undergo, when or after entering Canada, the COVID-19 molecular test, in which case the person must follow the instructions of the quarantine officer.

Exempted persons — subsections (1) and (1.2)

(4) Subsections (1) and (1.2) do not apply to

(a) a person referred to in Table 2 of Schedule 2; and

(b) a person referred to in subsection 2.4‍(2)‍.

Exempted persons — paragraph (1)‍(b)

(5) Paragraph (1)‍(b) does not apply to

(a) a fully vaccinated person who provides the evidence of COVID-19 vaccination that they are required to provide under this Order; and

(b) a person referred to in section 4.9.

Alternative testing protocol — on entry

2.4 (1) The persons referred to in subsection (2) who enter Canada must, subject to subsection (3) and in accordance with the instructions of a quarantine officer, undergo a COVID-19 molecular test in accordance with an alternative testing protocol that screens or diagnoses COVID-19 for the purpose of minimizing the risk of introduction or spread of COVID-19 and that takes into account the following factors:

(a) the number of tests;

(b) the test method of each test;

(c) the location where each test is administered;

(d) the frequency of the tests;

(e) the timing of the tests; and

(f) any extraordinary circumstances.

Persons subject to alternative testing protocol

(2) The persons undergoing a test in accordance with an alternative testing protocol under subsection (1) are

(a) a person or any member of a class of persons designated by the Chief Public Health Officer;

(b) a person who is less than 18 years of age and is not accompanied by a person who is 18 years of age or older; and

(c) a person referred to in subsection 4.7‍(1)‍.

Extraordinary circumstances

(3) A quarantine officer may, in extraordinary circumstances, release any person from the requirement to undergo a test in accordance with the alternative testing protocol, in which case the person must follow the instructions of the quarantine officer.

Exempted persons — positive result

(4) This section does not apply to a person who receives a positive result for any type of COVID-19 test.

Evidence of COVID-19 test — retention

2.5 (1) Every person who enters Canada must

(a) retain the evidence they are required to provide or have in their possession under subsection 2.1‍(1), 2.2‍(1) or 2.21‍(1) or paragraph 2.22‍(b) or evidence of a COVID-19 molecular test referred to in subsection 2.3‍(1) or (1.2) during the following periods:

(i) if the person is not required to isolate themselves, the 14-day period that begins on the day on which the person enters Canada and the period referred to in subsection 4.92‍(3) or paragraph 4.921‍(2)‍(e), and

(ii) if the person is required to isolate themselves, any isolation period;

(b) retain the evidence of the result for a test referred to in subsection 2.4‍(1) during the 14-day period that begins on the day on which the person receives the evidence of the test result; and

(c) provide, on request, the evidence referred to in paragraphs (a) and (b) to any official of the Government of Canada, including a public health official, or of the government of a province or to the local public health authority of the place where the person is located.

Designation

(2) The Chief Public Health Officer may designate any person as a public health official for the purposes of paragraph (1)‍(c)‍.

PART 3

Suitable Quarantine Plan and Other Measures

Suitable quarantine plan

3.1 (1) A suitable quarantine plan must meet the following requirements:

(a) it includes the civic address of the place where they plan to quarantine themselves during the 14-day period that begins on the day on which the person enters Canada;

(b) it includes their contact information for the 14-day period that begins on the day on which they enter Canada; and

(c) it indicates that the place of quarantine meets the conditions set out in subsection (2)‍.

Place of quarantine — conditions

(2) The conditions for the place of quarantine are the following:

(a) it allows the person to avoid all contact with other people with whom they did not travel unless they are a minor, in which case the minor can have contact with other people who are providing care and support to the minor and who reside with the minor until the expiry of the period referred to in paragraph 2.5‍(1)‍(a);

(b) it allows the person to avoid all contact with vulnerable persons or persons who provide care to those persons, unless the vulnerable person is a consenting adult or the parent, step-parent or dependent child in a parent-child relationship;

(c) it allows no other person to be present at the place, unless that person resides there habitually;

(d) it allows the person to have access to a bedroom at the place that is separate from the one used by persons who did not travel and enter Canada with that person;

(e) it allows the person to access the necessities of life without leaving that place; and

(f) it allows the person to avoid all contact with health care providers and persons who work or assist in a facility, home or workplace where vulnerable persons are present.

Suitable quarantine plan — requirement

3.2 (1) Subject to subsection (2), every person who enters Canada must provide to the Minister of Health, screening officer or quarantine officer a suitable quarantine plan that meets the requirements set out in subsection 3.1‍(1)‍.

Exception — contact information

(2) Instead of providing a suitable quarantine plan, a person referred to in Table 1 of Schedule 2 must provide to the Minister of Health, screening officer or quarantine officer their contact information for the 14-day period that begins on the day on which they enter Canada.

Timing

(3) The person who provides their suitable quarantine plan or their contact information must do so,

(a) if the person enters Canada by aircraft, before boarding the aircraft for the flight to Canada;

(b) if the person enters Canada by land, before entering Canada; or

(c) if the person enters Canada by water, before or when entering Canada.

Electronic means

(4) A person who enters Canada must provide their suitable quarantine plan or their contact information by electronic means specified by the Minister of Health, unless they are a member of a class of persons who, as determined by the Minister of Health, are unable to provide their plan by those electronic means for a reason such as a disability, inadequate infrastructure, a service disruption or a natural disaster, in which case the plan must be provided in the form and manner and at the time specified by the Minister of Health.

Persons in transit

(5) Subsections (1) and (2) do not apply to a person who plans to arrive at a Canadian airport on board an aircraft in order to transit to another country and to remain in a sterile transit area, as defined in section 2 of the Immigration and Refugee Protection Regulations, until they leave Canada.

Information — countries

3.3 (1) Every person who enters Canada must disclose to the Minister of Health, screening officer or quarantine officer the countries that they were in during the 14-day period before the day on which they enter Canada.

Information and evidence of vaccination

(2) Every person who enters Canada must

(a) disclose to the Minister of Health, screening officer or quarantine officer information related to their COVID-19 vaccination, including whether they received a COVID-19 vaccine, the brand name or any other information that identifies the vaccine that was administered, the dates on which the vaccine was administered and the number of doses received; and

(b) if they are a fully vaccinated person, provide the Minister of Health, screening officer or quarantine officer the evidence of COVID-19 vaccination referred to in subsection (4)‍.

Extraordinary circumstances

(3) A quarantine officer may, in extraordinary circumstances, release any person from the requirements referred to in subsection (2), in which case the person must follow the instructions of the quarantine officer.

Elements — evidence of vaccination

(4) Subject to subsection (5), the evidence of COVID-19 vaccination means evidence issued by a non-governmental entity that is authorized to issue the evidence of COVID-19 vaccination in the jurisdiction in which the vaccine was administered, by a government or by an entity authorized by a government, and must contain the following information:

(a) the name of the person who received the vaccine;

(b) the name of the government or the name of the entity;

(c) the brand name or any other information that identifies the vaccine that was administered; and

(d) the dates when the vaccine was administered or, if the evidence is one document issued for both doses and the document only specifies the date when the most recent dose was administered, that date.

Evidence of vaccination — translation

(5) The evidence of COVID-19 vaccination must be in English or French and any translation into English or French must be a certified translation.

Timing — countries

(6) A person who is required to provide the information referred to in subsection (1) must do so,

(a) if the person enters Canada by aircraft, before boarding the aircraft for the flight to Canada;

(b) if the person enters Canada by land, before entering Canada; or

(c) if the person enters Canada by water, before or when entering Canada.

Timing — COVID-19 vaccination

(7) A person who is required to provide the information referred to in paragraph (2)‍(a) or the evidence of COVID-19 vaccination referred to in paragraph (2)‍(b) must do so,

(a) if the person enters Canada by aircraft,

(i) in the case of a foreign national who seeks to enter Canada based on their status as a fully vaccinated person, before boarding the aircraft for the flight to Canada, or

(ii) in all other cases, before entering Canada;

(b) if the person enters Canada by land, before entering Canada; or

(c) if the person enters Canada by water, before or when entering Canada.

Electronic means

(8) A person who enters Canada must provide the information referred in subsection (1) and paragraph (2)‍(a) and the evidence of COVID-19 vaccination referred to in paragraph (2)‍(b) that they are required to provide by electronic means specified by the Minister of Health, unless they are a member of a class of persons who, as determined by the Minister of Health, are unable to provide their information by those electronic means for a reason such as a disability, inadequate infrastructure, a service disruption or a natural disaster, in which case the information must be provided in the form and manner and at the time specified by the Minister of Health.

Evidence of vaccination — retention

(9) Every person who enters Canada and who is required to provide evidence of COVID-19 vaccination must, during the period referred to in paragraph 2.5‍(1)‍(a),

(a) retain the evidence of COVID-19 vaccination;

(b) if the evidence of COVID-19 vaccination is a certified translation, retain the original version of that evidence; and

(c) provide, on request, the evidence of COVID-19 vaccination and, if , the original version of that evidence to any official of the Government of Canada, including a public health official, or of the government of a province or to the local public health authority of the place where the person is located.

Answers, information and records

(10) Every person who enters Canada must, for the purposes of the administration of this Order, before entering Canada and during the period referred to in 2.5‍(1)‍(a),

(a) answer any relevant questions asked by a screening officer, a quarantine officer, a peace officer or a public health official designated under subsection (11) or asked on behalf of the Chief Public Health Officer; and

(b) provide to an officer or official referred to in paragraph (a) or the Chief Public Health Officer any information or record in the person’s possession that the officer, official or Chief Public Health Officer may request, in the form and manner and at the time specified by the officer, official or Chief Public Health Officer.

Designation

(11) The Chief Public Health Officer may designate any person as a public health official.

Mask

3.4 (1) Every person who enters Canada and who is required to quarantine or isolate themselves must, during the period referred to in 2.5‍(1)‍(a), wear a mask that a screening officer or quarantine officer considers suitable to minimize the risk of introduction or spread of COVID-19,

(a) while they are entering Canada; and

(b) while they are in transit to a place of quarantine or isolation, a health care facility or their place of departure from Canada, unless they are alone in a private conveyance.

Persons not subject to quarantine

(2) Every person who enters Canada and who, under section 4.5, subsection 4.7‍(1) or sections 4.8, 4.9 or 4.91, is not required to enter or remain in quarantine must, during the 14-day period that begins on the day on which they enter Canada,

(a) wear a mask that a screening officer or quarantine officer considers suitable to minimize the risk of introduction or spread of COVID-19 when they are in public settings, including when entering Canada; and

(b) maintain a list of the names and contact information of each person with whom the person comes into close contact and the locations visited during that period.

Exempted persons

(3) This section does not apply to a person who

(a) needs to remove their mask for security or safety reasons;

(b) is less than two years of age; or

(c) is at least two years of age but less than six years of age who is unable to tolerate wearing a mask.

PART 4

Quarantine of Asymptomatic Persons

Requirements — quarantine

4.1 Every person who enters Canada and who does not exhibit signs and symptoms of COVID-19 must quarantine themselves without delay in accordance with the instructions provided by a screening officer or quarantine officer, and remain in quarantine until the expiry of the 14-day period that begins on the day on which the person enters Canada, in a place

(a) that meets the conditions set out in subsection 3.1‍(2); and

(b) that is considered suitable by the Chief Public Health Officer, screening officer or quarantine officer, having regard to the risk to public health posed by COVID-19, the likelihood or degree of exposure of the person to COVID-19 prior to entry into Canada and any other factor that the Chief Public Health Officer, screening officer or quarantine officer considers relevant.

Additional requirements

4.2 A person who is required to quarantine under this Order must

(a) report their arrival at, and the civic address of, their place of quarantine within 48 hours after entering Canada, in the case of a person referred to in section 4.1, or after their arrival at the place of quarantine, in the case of a person referred to in subsection 4.92‍(3), to the Minister of Health, screening officer or quarantine officer, by electronic means specified by the Minister of Health or by telephone using a number specified by the Minister of Health, unless they are a member of a class of persons who, as determined by the Minister of Health, are unable to report that information by those means for a reason such as a disability, inadequate infrastructure, a service disruption or a natural disaster, in which case the reporting must be done in the form and manner and at the time specified by the Minister of Health; and

(b) while they remain in quarantine,

(i) monitor for signs and symptoms of COVID-19, and

(ii) report daily on their health status relating to signs and symptoms of COVID-19 to the Minister of Health, screening officer or quarantine officer, by electronic means specified by the Minister of Health or by telephone using a number specified by the Minister of Health, unless they are a member of a class of persons who, as determined by the Minister of Health, are unable to report that information by those means for a reason such as a disability, inadequate infrastructure, a service disruption or a natural disaster, in which case the reporting must be done in the form and manner and at the time specified by the Minister of Health.

Unable to quarantine

4.3 (1) A person who is required to quarantine under this Order is considered unable to quarantine themselves if

(a) the person refuses to undergo a COVID-19 molecular test under subsection 2.3‍(1) or (1.2) or 2.4‍(1) that they are required to undergo;

(b) the person has not provided a suitable quarantine plan in accordance with this Order; or

(c) the person cannot quarantine themselves in accordance with section 4.1 or subsection 4.92‍(3) or 4.921‍(2)‍.

Quarantine facility or other suitable place

(2) A person who, at the time of entry into Canada or at any other time during the 14-day period referred to in section 4.1 or subsection 4.92‍(3) or paragraph 4.921‍(2)‍(e), is considered unable to quarantine themselves must

(a) if directed by a screening officer or quarantine officer, board any means of transportation provided by the Government of Canada for the purpose of transporting them to a quarantine facility or transferring them between quarantine facilities; and

(b) enter into quarantine without delay

(i) at the quarantine facility in accordance with the instructions provided by a screening officer or quarantine officer and remain in quarantine at the facility or at any other quarantine facility to which they are subsequently transferred until the expiry of that period, or

(ii) at any other place that the quarantine officer considers suitable, in accordance with the instructions provided by the quarantine officer, and remain in quarantine at the place or at any other place to which they are subsequently transferred until the expiry of that period.

Change of place

(3) A person may, with the authorization of a quarantine officer, leave a quarantine facility before the expiry of the 14-day period that begins on the day on which the person enters Canada or the period referred to in subsection 4.92‍(3) or paragraph 4.921‍(2)‍(e), in order to quarantine themselves in a place that meets the conditions set out in section 4.1 and must, if applicable, meet the requirements set out in section 4.2.

Choice of quarantine facility

(4) In choosing a quarantine facility for the purposes of subsection (2), the Chief Public Health Officer must consider the following factors:

(a) the risk to public health posed by COVID-19;

(b) the feasibility of controlling access to the quarantine facility;

(c) the capacity of the quarantine facility;

(d) the feasibility of quarantining persons at the facility;

(e) the likelihood or degree of exposure of the person to COVID-19 prior to entry into Canada; and

(f) any other factor that the Chief Public Health Officer considers relevant.

Unable to quarantine — additional requirements

4.4 A person referred to in subsection 4.3‍(2) or (3) must,

(a) report their arrival at the quarantine facility or a place of quarantine to a screening officer or quarantine officer within 48 hours after entering the quarantine facility or the place of quarantine;

(b) while they remain in quarantine in accordance with paragraph 4.3‍(2)‍(b)

(i) monitor for signs and symptoms of COVID-19, and

(ii) report daily to a screening officer or quarantine officer at the quarantine facility on their health status relating to signs and symptoms of COVID-19; and

(c) while they remain at a quarantine facility, undergo any health assessments that a quarantine officer requires.

Exempted persons — quarantine

4.5 Sections 4.1 to 4.4 do not apply to a person referred to in Table 1 of Schedule 2 if

(a) the person meets the applicable requirements referred to in subsection 2.1‍(1), 2.2‍(1) or 2.21‍(1) or paragraph 2.22‍(b) or the person does not meet the requirements but subsequently receives a negative result for a COVID-19 molecular test or the authorization of a quarantine officer to leave a quarantine facility or any other place that the quarantine officer considered suitable; and

(b) the person monitors for signs and symptoms of COVID-19 until the expiry of the 14-day period that begins on the day on which the person enters Canada.

Exempted persons — medical reason

4.6 (1) Sections 4.1 to 4.4 do not apply to a person

(a) during any medical emergency or essential medical services or treatments that require the person to visit or be taken to a health care facility that, if the person is in a quarantine facility, is outside that quarantine facility; or

(b) during the time necessary to enable the person to undergo a COVID-19 molecular test.

Accompanying person

(2) If the person exempted from the quarantine requirements under subsection (1) is a dependent child or requires assistance in accessing medical services or treatments, the exception set out in that subsection extends to one other person who accompanies the dependent child or the person requiring assistance.

Other cases

(3) The requirements set out in sections 4.1 to 4.4 do not apply to a person if

(a) the person is admitted into a health care facility and is the subject of a provincial or local public health order that is inconsistent with those requirements; or

(b) those requirements are inconsistent with another requirement imposed on them under the Quarantine Act.

Exempted persons — compassionate grounds

4.7 (1) Subject to subsection (3), sections 4.1, 4.3 and 4.4 do not apply to a person if the Minister of Health

(a) determines that the person does not intend to quarantine themselves or to remain in quarantine, as the case may be, in order to engage in one of the following activities:

(i) to provide support to a Canadian citizen, permanent resident of Canada, temporary resident, protected person or person registered as an Indian under the Indian Act who is residing in Canada and who is deemed to be critically ill by a health care practitioner who is licensed in Canada, or to attend to their death,

(ii) to provide care for a Canadian citizen, permanent resident of Canada, temporary resident, protected person or person registered as an Indian under the Indian Act who is residing in Canada and who is deemed by a health care practitioner who is licensed in Canada to require support for a medical reason, or

(iii) to attend a funeral or end-of-life ceremony;

(b) has not received written notice from the government of the province where an activity referred to in paragraph (a) will take place indicating that government opposes the non-application of sections 4.1, 4.3 and 4.4 to persons who engage in that activity in that province;

(c) determines, if the person seeks to engage in an activity referred to in paragraph (a) at a location other than a public outdoor location, that the person in charge of the location does not object to the former person being present to engage in that activity at that location; and

(d) determines that an activity referred to in paragraph (a) is expected to take place during the 14-day period that begins on the day on which the person enters Canada and receives evidence that the circumstances necessitate a release from the requirement to quarantine.

Conditions

(2) Subsection (1) applies while the person engages in one of the activities referred to in paragraph (1)‍(a) and if the person complies with all conditions imposed on them by the Minister of Health to minimize the risk of introduction or spread of COVID-19.

Exempted persons

(3) Subsection (1) does not apply to a person who

(a) does not meet the applicable requirements referred to in subsection 2.1‍(1), 2.2‍(1) or 2.21‍(1) or paragraph 2.22‍(b), unless they receive a negative result for a COVID-19 molecular test or the authorization of a quarantine officer to leave a quarantine facility or any other place that the quarantine officer considered suitable; or

(b) develops signs and symptoms of COVID-19 or receives a positive result for a COVID-19 test.

Orders made under Quarantine Act

(4) For the purposes of any order made under section 58 of the Quarantine Act, the non-application of sections 4.1, 4.3 and 4.4 under this section is a limited release from the requirement to quarantine on compassionate grounds.

Exempted persons — fully vaccinated persons

4.8 Sections 4.1 to 4.4 do not apply to a fully vaccinated person who enters Canada if

(a) in the case of a person who is not referred to in paragraph 2.3‍(1.1)‍(c), the person

(i) provides the information referred to in paragraph 3.3‍(2)‍(a) in accordance with subsections 3.3‍(3), (8) and (10),

(ii) provides the evidence referred to in paragraph 3.3‍(2)‍(b) in accordance with subsections 3.3‍(3) to (5) and (8) to (10),

(iii) undergoes the COVID-19 molecular test referred to in paragraph 2.3‍(1)‍(a) or subsection 2.3‍(1.2) or 2.4‍(1) that they are required to undergo, and

(iv) monitors for signs and symptoms of COVID-19 until the expiry of the 14-day period that begins on the day on which the person enters Canada; and

(b) in the case of a person referred to in paragraph 2.3‍(1.1)‍(c), the person

(i) receives a negative result for a COVID-19 molecular test referred to in paragraph 2.3‍(1)‍(a) or subsection 2.4‍(1),

(ii) provides the information referred to in paragraph 3.3‍(2)‍(a) in accordance with subsections 3.3‍(3), (8) and (10),

(iii) provides the evidence referred to in paragraph 3.3‍(2)‍(b) in accordance with subsections 3.3‍(3) to (5) and (8) to (10), and

(iv) monitors for signs and symptoms of COVID-19 until the expiry of the 14-day period that begins on the day on which the person enters Canada.

Exempted persons — less than 12 years of age

4.9 Sections 4.1 to 4.4 do not apply to a person who is not a fully vaccinated person and is less than 12 years of age if

(a) in the case of a person who is not referred to in paragraph 2.3‍(1.1)‍(d), the person

(i) enters Canada with one of their parents, step-parents, guardians or tutors who meets the conditions set out in paragraph 4.8‍(a),

(ii) meets the applicable requirements referred to in subsection 2.1‍(1), 2.2‍(1) or 2.21‍(1) or paragraph 2.22‍(b) or they do not meet the requirements but subsequently receive a negative result for a COVID-19 molecular test or the authorization of a quarantine officer to leave a quarantine facility or any other place that the quarantine officer considered suitable,

(iii) undergoes the COVID-19 molecular test referred to in paragraph 2.3‍(1)‍(a) or subsection 2.3‍(1.2) or 2.4‍(1) that they are required to undergo, and

(iv) monitors themselves, or the parent, step-parent, guardian or tutor referred to in subparagraph (i) monitors them, for signs and symptoms of COVID-19 until the expiry of the 14-day period that begins on the day on which the person enters Canada;

(b) in the case of a person referred to in paragraph 2.3‍(1.1)‍(d) who is five years of age or older, the person

(i) enters Canada with one of their parents, step-parents, guardians or tutors who is a person referred to in paragraph 2.3‍(1.1)‍(c) and who meets the conditions set out in paragraph 4.8‍(b),

(ii) receives a negative result for a COVID-19 molecular test referred to in paragraph 2.3‍(1)‍(a) or subsection 2.4‍(1), and

(iii) monitors themselves, or the parent, step-parent, guardian or tutor referred to in subparagraph (i) monitors them, for signs and symptoms of COVID-19 until the expiry of the 14-day period that begins on the day on which the person enters Canada; and

(c) in the case of a person referred to in paragraph 2.3‍(1.1)‍(d) who is less than five years of age, the person enters Canada with one of their parents, step-parents, guardians or tutors who is a person referred to in paragraph 2.3‍(1.1)‍(c) and who meets the conditions set out in paragraph 4.8‍(b)‍.

Contraindication

4.91 (1) For the purposes of this section, a contraindication to a COVID-19 vaccine dosage regimen is a medical reason that prevents a person in a class of persons from completing a COVID-19 vaccine dosage regimen according to

(a) the terms of market authorization of the relevant COVID-19 vaccines in the country in which the person resides; or

(b) the opinion of the Minister of Health, on the recommendation of the Chief Public Health Officer, having regard to scientific evidence related to the health effects of a COVID-19 vaccine dosage regimen or any other relevant information.

Exempted persons — persons with contraindications

(2) Sections 4.1 to 4.4 do not apply to a person 12 years of age or older and who is not a fully vaccinated person if

(a) they have in their possession written evidence from a physician who is licensed to practise medicine, or other evidence considered reliable by the Minister of Health, on the recommendation of the Chief Public Health Officer, confirming that they have a contraindication to a COVID-19 vaccine dosage regimen; and

(b) during the 14-day period that begins on the day on which the person enters Canada,

(i) they meet the applicable requirements referred to in subsection 2.1‍(1), 2.2‍(1) or 2.21‍(1) or paragraph 2.22‍(b) or they do not meet the requirements but subsequently receive a negative result for a COVID-19 molecular test or the authorization of a quarantine officer to leave a quarantine facility or any other place that the quarantine officer considered suitable,

(ii) they undergo the COVID-19 molecular tests referred to in subsection 2.3‍(1) or (1.2) or 2.4‍(1) that they are required to undergo,

(iii) they avoid all contact with vulnerable persons,

(iv) they monitor for signs and symptoms of COVID-19, and

(v) they comply with all conditions imposed on them by the Minister of Health to minimize the risk of introduction or spread of COVID-19.

Evidence — translation

(3) The evidence referred to in paragraph (2)‍(a) must be in English or French and any translation into English or French must be a certified translation.

Evidence — retention

(4) Every person who enters Canada and who is required to have in their possession the evidence referred to in paragraph (2)‍(a) must, during the applicable period referred to in paragraph 2.5‍(1)‍(a),

(a) retain the evidence;

(b) if the evidence is a certified translation, retain the original version of that evidence; and

(c) provide, on request, the evidence and, if applicable, the original version of that evidence to any official of the Government of Canada, including a public health official, or of the government of a province or to the local public health authority of the place where the person is located.

Signs and symptoms or positive test result

4.92 (1) Every person, other than a person referred to in section 4.9 or 4.921, who develops signs and symptoms of COVID-19 or receives a positive result for a COVID-19 molecular test referred to in subsection 2.3‍(1) or (1.2) or 2.4‍(1) that they are required to undergo, before the expiry of the 14-day period that begins on the day on which the person enters Canada, must

(a) report the signs and symptoms or positive result without delay to the Minister of Health, screening officer or quarantine officer by the means specified by the Minister of Health; and

(b) isolate themselves in accordance with the requirements set out in Part 5 for a 10-day period that begins on

(i) in the case of a person who develops signs and symptoms of COVID-19, the day on which the person developed the signs and symptoms, or

(ii) in the case of a person who receives a positive result,

(A) the date the specimen of the person was collected that was validated and indicated by the test provider to the Minister of Health, screening officer or quarantine officer, or

(B) if the test provider did not validate the date when the specimen was collected, the test result date that the test provider indicated to the person or to the Minister of Health, screening officer or quarantine officer.

Persons less than 12 years of age

(2) If the person referred to in section 4.9 develops signs and symptoms of COVID-19 or receives a positive result for a COVID-19 molecular test referred to in subsection 2.3‍(1) or (1.2) or 2.4‍(1) that they are required to undergo before the expiry of the 14-day period that begins on the day on which the person enters Canada,

(a) they or the parent, step-parent, guardian or tutor referred to in section 4.9‍ must report the signs and symptoms or positive result without delay to the Minister of Health, screening officer or quarantine officer by the means specified by the Minister of Health; and

(b) they must isolate themselves in accordance with the requirements set out in Part 5 for a 10-day period that begins on

(i) in the case of a person who develops signs and symptoms of COVID-19, the day on which the person developed signs and symptoms of COVID-19, or

(ii) in the case of a person who receives a positive result,

(A) the date the specimen of the person was collected that was validated and indicated by the test provider to the Minister of Health, screening officer or quarantine officer, or

Exposure to a person

(3) Every person who enters Canada, other than a person referred to in subsection 4.921‍(2), after travelling with a person who exhibits signs and symptoms of COVID-19 or receives a positive result for any type of COVID-19 test, before the expiry of the 14-day period that begins on the day on which the person enters Canada, must quarantine themselves in a place that meets the conditions set out in section 4.1 and must meet the requirements set out in Part 4 during the 14-day period that begins on the day on which the person was most recently exposed to the other person.

Signs and symptoms or positive test result — cruise ship

4.921 (1) Every person who enters Canada on board a cruise ship and who disembarks the cruise ship after they develop signs and symptoms of COVID-19 or receive a positive result for a COVID-19 molecular test or a COVID-19 antigen test before the expiry of the 14-day period that begins on the day on which the person enters Canada must isolate themselves in accordance with the requirements set out in Part 5.

Exposure to a person

(2) Every person who enters Canada on board a cruise ship after travelling with a person who exhibits signs and symptoms of COVID-19 or receives a positive result for any type of COVID-19 test before the expiry of the 14-day period that begins on the day on which that person enters Canada must, if they disembark from the cruise ship,

(a) prior to disembarkation, have a suitable quarantine plan that is

(i) developed by the person and provided by that person to the authorized representative of the cruise ship, or

(ii) developed by the authorized representative of the cruise ship if

(A) the person does not develop their own quarantine plan, or

(B) a quarantine officer determines that the quarantine plan developed by the person does not meet the conditions set out in paragraph (b);

(b) quarantine themselves in accordance with a quarantine plan that contains

(i) the civic address of the place of quarantine that satisfies the conditions set out in section 4.1, where the person will remain in quarantine during the applicable quarantine period,

(ii) the period of quarantine determined under paragraph (e), including the number of days that the person remained in a suitable place of quarantine on board the cruise ship, and

(iii) the information required to contact the person during the period of quarantine;

(c) travel directly to the place of quarantine referred to in subparagraph (b)‍(i);

(d) follow the instructions of a screening officer or quarantine officer that were provided to the person prior to disembarkation by the authorized representative under subsection (2.2)‍(c); and

(e) remain in quarantine until the expiry of the 14-day period that begins on the day on which the person was most recently exposed to the other person.

Suitable quarantine plan

(2.1) A quarantine plan for a person referred to in subsection (2) is suitable if, prior to the disembarkation of that person, the authorized representative of the cruise ship

(a) provides the quarantine plan to a screening officer or quarantine officer under subsection (2.2)‍(b); and

(b) receives confirmation from a quarantine officer that the quarantine plan satisfies the conditions set out in paragraph (2)‍(b)‍.

Requirements — authorized representative

(2.2) An authorized representative of a cruise ship must

(a) if the person referred to in subsection (2) has not developed their own quarantine plan, organize for the person and any person travelling with them who is a dependent child or is 22 years of age or older and dependent on them for care or support by reason of mental or physical limitation,

(i) a place of quarantine that satisfies the conditions set out in section 4.1 and that is indicated in the quarantine plan referred to in paragraph (2)‍(a), and

(ii) daily meals while the person remains at the place of quarantine referred to in subparagraph (i);

(b) provide the quarantine plan that satisfies the conditions set out in paragraph (2)‍(b) to a screening officer or quarantine officer prior to the disembarkation of the person referred to in subsection (2); and

(c) provide to a person referred to in subsection (2) instructions of a screening officer or quarantine officer prior to the disembarkation of that person.

Exception — leaving Canada

4.93 A person to whom section 4.1 or 4.3 or subsection 4.92‍(3) or 4.921‍(2) applies may leave Canada before the expiry of the 14-day period set out in those provisions only if they quarantine themselves until they depart from Canada.

PART 5

Isolation of Symptomatic Persons

Requirements — isolation

5.1 (1) Every person who enters Canada, other than a person who enters Canada on board a cruise ship, and who has reasonable grounds to suspect they have COVID-19, exhibits signs and symptoms of COVID-19, knows that they have COVID-19 or has received a positive result for any type of COVID-19 test that was performed on a specimen collected less than 10 days before the day on which they enter Canada or on the day on which they enter Canada must

(a) isolate themselves without delay in accordance with the instructions provided by a screening officer or quarantine officer in a place that meets the conditions set out in subsection (2); and

(b) remain in isolation until the expiry of the 10-day period that begins on the day on which the person enters Canada or any other applicable isolation period.

Cruise ship

(1.1) A person referred to in subsection 4.921‍(1) or a person who enters Canada on board a cruise ship and who has reasonable grounds to suspect they have COVID-19, exhibits signs and symptoms of COVID-19, knows that they have COVID-19 or has received a positive result for any type of COVID-19 test that was performed on a specimen collected less than 10 days before the day on which they enter Canada or on the day on which they enter Canada and who disembarks in Canada from the cruise ship must

(a) prior to disembarkation, have a suitable isolation plan that is

(i) developed by the person and provided by that person to the authorized representative of the cruise ship, or

(ii) developed by the authorized representative of the cruise ship if

(A) the person does not develop their own isolation plan, or

(B) a quarantine officer determines that the isolation plan developed by the person does not meet the conditions set out in paragraph (b);

(b) isolate themselves in accordance with the isolation plan referred to in paragraph (a) that contains

(i) the civic address of the place of isolation, that satisfies the conditions set out in subsection (2), where the person will remain in isolation during the applicable isolation period,

(ii) the period of isolation determined in accordance with paragraph (e), including the number of days that the person remained in a suitable place of isolation on board the cruise ship, and

(iii) the information required to contact the person during the period of isolation;

(c) travel directly to the place of isolation referred to in subparagraph (b)‍(i) using a private conveyance that is shared with only persons who travelled and entered Canada with the person and that is

(i) in the case where the isolation plan was developed by the authorized representative of the cruise ship, provided by the authorized representative under subparagraph (1.3)‍(a)‍(ii), or

(ii) in the case where the person has developed their own isolation plan, organized by the person;

(d) follow the instructions of a screening officer or quarantine officer that were provided to the person prior to disembarkation by the authorized representative of the cruise ship under paragraph (1.3)‍(c); and

(e) remain in isolation until the expiry of the 10-day period that begins on

(i) in the case of a person who develops signs and symptoms of COVID-19 and who does not undergo a COVID-19 molecular test or a COVID-19 antigen test, the day on which the person disembarks from the cruise ship, or

(ii) in the case of a person who receives a positive result for a COVID-19 molecular test or a COVID-19 antigen test that was performed on a specimen collected while the person was on board the cruise ship,

(A) the date the specimen of the person was collected that was validated and indicated by the test provider to the authorized representative of the cruise ship, or

(B) if the test provider did not validate the date when the specimen was collected, the test result date indicated by the test provider to the person or to the authorized representative of the cruise ship.

Suitable isolation plan

(1.2) An isolation plan for a person referred to in subsection (1.1) is suitable if, prior to the disembarkation of that person, the authorized representative of the cruise ship

(a) provides the isolation plan to a screening officer or quarantine officer under paragraph (1.3)‍(b); and

(b) receives confirmation from a quarantine officer that the isolation plan satisfies the conditions set out in paragraph (1.1)‍(b)‍.

Requirements — authorized representative

(1.3) An authorized representative of a cruise ship must

(a) if a person referred to in subsection (1.1) has not developed their own isolation plan, organize for the person and any person travelling with them who is a dependent child or is 22 years of age or older and dependent on them for care or support by reason of mental or physical limitation,

(i) a place of isolation that satisfies the conditions set out in subsection (2) and that is indicated in the isolation plan referred to in paragraph (1.1)‍(a),

(ii) a private conveyance that allows the person to travel directly to the place of isolation and that is shared with only persons who travelled and entered Canada with the person, and

(iii) daily meals while the person remains at the place of isolation referred to in subparagraph (i);

(b) provide the isolation plan that satisfies the conditions set out in paragraph (1.1)‍(b) to a screening officer or quarantine officer prior to the disembarkation of the person referred to in subsection (1.1); and

(c) provide to a person referred to in subsection (1.1) the instructions of a screening officer or quarantine officer prior to the disembarkation of that person.

Place of isolation — conditions

(2) The applicable conditions for the place of isolation are the following:

(a) it is directly accessible by a private conveyance that is shared with only persons who travelled and entered Canada with the person;

(b) it allows the person to remain in isolation during the applicable isolation period;

(c) it allows the person to avoid all contact with vulnerable persons or persons who provide care to those persons, unless the vulnerable person is a consenting adult or the parent, step-parent or dependent child in a parent-child relationship and no alternative care arrangement is available;

(d) it allows the person to avoid all contact with any other people unless they are required or are directed to go to a place to seek medical care, in which case they must meet the requirements set out in subsection 5.5‍(3);

(e) it allows the person to have access to a bedroom that is separate from those used by all other persons, or if not, at the discretion of the quarantine officer, it allows the person to follow the instructions of the quarantine officer;

(f) it allows the person to have access to a bathroom that is separate from those used by all other persons, or if not, at the discretion of the quarantine officer, it allows the person to follow the instructions of the quarantine officer;

(g) it allows the person to have access to the necessities of life without leaving that place;

(h) it allows the person to access local public health services;

(i) it allows the person to provide a specimen collected for a COVID-19 molecular test for the purposes of subsection 2.3‍(1); and

(j) it is considered suitable by the Chief Public Health Officer, screening officer or quarantine officer, having regard to the risk to public health posed by COVID-19, the likelihood or degree of exposure of the person to COVID-19 prior to entry into Canada and any other factor that the Chief Public Health Officer, screening officer or quarantine officer considers relevant.

Additional requirements

5.2 A person who is required to isolate under this Order must

(a) within 48 hours after entering Canada, in the case of a person referred to in subsection 5.1‍(1), or after the start of their period of isolation, in the case of a person referred to in subsection 4.92‍(1) or (2), report their arrival at, and the civic address of, the place of isolation to the Minister of Health, screening officer or quarantine officer, by electronic means specified by the Minister of Health or by telephone using a number specified by the Minister of Health, unless they are a member of a class of persons who, as determined by the Minister of Health, are unable to report that information by those means for a reason such as a disability, inadequate infrastructure, a service disruption or a natural disaster, in which case the reporting must be done in the form and manner and at the time specified by the Minister of Health;

(b) while they remain in isolation in accordance with section 5.1, undergo any health assessments that a quarantine officer requires, monitor their signs and symptoms of COVID-19 and, if they require additional medical care, report to the public health authority specified by a screening officer or quarantine officer; and

(c) within 24 hours of receiving a positive result for a COVID-19 molecular test referred to in subsection 2.3‍(1) or (1.2) or 2.4‍(1) that they are required to undergo and that was performed on a specimen collected during the applicable isolation period — whether the result was received before or after the expiry of that period — report the result to the Minister of Health, screening officer or quarantine officer by the means specified by the Minister of Health.

Unable to isolate

5.3 (1) A person referred to in subsection 4.92‍(1) or (2) or 5.1‍(1) or (1.1) is considered unable to isolate themselves if

(a) the person refuses to undergo a COVID-19 molecular test under subsection 2.3‍(1) or 2.4‍(1) that they are required to undergo;

(b) it is necessary for the person to use public transportation, including an aircraft, bus, train, subway, taxi or ride-sharing service, to travel from the place where they enter Canada to the place where they will isolate themselves; or

(c) the person cannot isolate themselves in accordance with subsection 4.92‍(1) or (2), 5.1‍(1) or (1.1)‍.

Quarantine facility or other suitable place

(2) A person who, at the time of entry into Canada or at any other time during the applicable isolation period referred to in subsection 4.92‍(1) or (2) or 5.1‍(1) or subparagraph 5.1‍(1.1)‍(b)‍(ii), is considered unable to isolate themselves must

(b) enter into isolation without delay

(i) at the quarantine facility in accordance with the instructions provided by a screening officer or quarantine officer and remain in isolation at the facility or at any other quarantine facility to which they are subsequently transferred until the expiry of that period, or

(ii) at any other place that the quarantine officer considers suitable, in accordance with the instructions provided by the quarantine officer, and remain in isolation at the place or at any other place to which they are subsequently transferred until the expiry of that period.

Change of place

(3) A person may, with the authorization of a quarantine officer, leave a quarantine facility or any place of isolation referred to in subparagraph (2)‍(b)‍(i) before the expiry of the applicable isolation period in order to isolate themselves in a place that meets the conditions set out in subsection 5.1‍(2), and must, if applicable, meet the requirements set out in section 5.2.

Choice of quarantine facility

(4) In choosing a quarantine facility for the purposes of subsection (2), the Chief Public Health Officer must consider the factors set out in subsection 4.3‍(4), with any necessary modifications.

Unable to isolate — additional requirements

5.4 The person referred to in subsection 5.3‍(2) or (3) must

(a) report their arrival at the quarantine facility or the place of isolation, as the case may be, to a screening officer or quarantine officer within 48 hours after entering the facility or the place; and

(b) while they remain in isolation in accordance with paragraph 5.3‍(2)‍(b), undergo any health assessments that a quarantine officer requires, monitor their signs and symptoms of COVID-19 and, if they require additional medical care, report to the public health authority specified by a screening officer or quarantine officer.

Exempted persons — medical reason

5.5 (1) Sections 5.1 to 5.4 do not apply to a person who meets the requirements set out in subsection (3)

(b) during the time necessary to enable the person to undergo a COVID-19 molecular test.

Accompanying person

(2) If the person to whom isolation requirements do not apply under subsection (1) is a dependent child, the exception in that subsection extends to one other person who accompanies the dependent child.

Requirements

(3) For the purposes of subsection (1) and (2), the person must

(a) wear a mask to go to and return from a health care facility or a place to undergo a COVID-19 molecular test;

(b) not take public transportation, including an aircraft, bus, train, subway, taxi or ride-sharing service, to go to and return from that facility or place; and

(c) not go to any other place.

Other cases

(4) The requirements set out in sections 5.1 to 5.4 do not apply to a person if

(a) the person is admitted into a health care facility and is the subject of a provincial or local public health order that is inconsistent with those requirements; or

(b) the requirements are inconsistent with another requirement imposed on the person under the Quarantine Act.

Positive result — requirements

5.6 If a person receives a positive result for a COVID-19 molecular test referred to in subsection 2.3‍(1) or (1.2) or 2.4‍(1) that they are required to undergo while they isolate themselves for a reason other than having received a positive result for any type of COVID-19 test, the associated requirements continue to apply and the isolation period in progress is replaced by a new 10-day isolation period that begins on

(a) the date the specimen of the person was collected that was validated and indicated by the test provider to the Minister of Health, screening officer or quarantine officer; or

(b) if the test provider did not validate the date when the specimen was collected, the test result date that the test provider indicated to the person or to the Minister of Health, screening officer or quarantine officer.

Exception — leaving Canada

5.7 A person who must isolate themselves in accordance with this Order cannot leave Canada before the expiry of the applicable isolation period unless the person

(a) leaves Canada in a private conveyance and at the discretion of and in accordance with the instructions of a quarantine officer; or

(b) remains in isolation on board a cruise ship for the duration of their time in Canada and leaves Canada on board that cruise ship and at the discretion of and in accordance with the instructions of a quarantine officer.

PART 6

Powers and Obligations

Powers and obligations

6.1 For greater certainty,

(a) this Order does not affect any of the powers and obligations set out in the Quarantine Act;

(b) this Order does not affect any of the powers and obligations under the Food and Drugs Act;

(c) this Order may be administered and enforced using electronic means; and

(d) any instruction to be followed under this Order includes any instruction that is provided after the time of entry into Canada.

PART 7

Amendments, Cessation of Effect, Repeal and Coming into Force

Amendments to Previous Order

Definition of previous Order

7.1 In section 7.2, previous Order means the Minimizing the Risk of Exposure to COVID-19 in Canada Order (Quarantine, Isolation and Other Obligations), P.C. 2022-178, February 26, 2022.

7.2 Section 7.1 of the previous Order is replaced by the following:

April 1, 2022

7.1 This Order ceases to have effect at 00:00:59 Eastern Daylight Time on April 1, 2022.

Amendments to this Order

7.3 Sections 1.1 to 6.1 of this Order are replaced by the following: